title: Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon.
abstract: A small number of patients with haemangioma need treatment for serious complications such as Kasabach-Merritt syndrome, cardiac failure and obstruction of the airway. We report on the management of an infant with Kasabach-Merritt syndrome.
authors.affiliation: Department of Neonatal and Intensive Care Medicine, Royal Hospital for Sick Children, Bristol, England.
authors.forename: J J
authors.initials: JJ
authors.lastname: Ettlinger
authors.forename: P J
authors.initials: PJ
authors.lastname: Fleming
authors.forename: H S
authors.initials: HS
authors.lastname: Joffe
authors.forename: C T
authors.initials: CT
authors.lastname: Kennedy
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005153:Facial Neoplasms / Q000628:therapy*; D006392:Hemangioma, Cavernous / Q000628:therapy*; D006801:Humans; D007231:Infant, Newborn; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D013577:Syndrome; D013921:Thrombocytopenia / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha